aldosterone receptor - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 67149

<< First< Prev

Page of 3358

Next >Last >>

Select item 114728231.

Aldosterone: Renal Action & Physiological Effects

Jermaine G. Johnston, Amanda K. Welch, Brian D. Cain, Peter P. Sayeski, Michelle L. Gumz, Charles S. Wingo

Compr Physiol. Author manuscript; available in PMC 2024 Oct 14.

Published in final edited form as: Compr Physiol. 2023 Mar 30; 13(2): 4409–4491. Published online 2023 Mar 30. doi: 10.1002/cphy.c190043

PMCID:: PMC11472823

Abstract Article PDF–3.5M

Select item 86141242.

Aldosterone and the mineralocorticoid receptor in renal injury: A potential therapeutic target in feline chronic kidney disease

Sarah Spencer, Caroline Wheeler‐Jones, Jonathan Elliott

J Vet Pharmacol Ther. 2020 May; 43(3): 243–267. Published online 2020 Mar 3. doi: 10.1111/jvp.12848

PMCID:: PMC8614124

Abstract Article PDF–1.1M

Select item 102960743.

Aldosterone: Essential for Life but Damaging to the Vascular Endothelium

Michael Crompton, Laura J. Skinner, Simon C. Satchell, Matthew J. Butler

Biomolecules. 2023 Jun; 13(6): 1004. Published online 2023 Jun 17. doi: 10.3390/biom13061004

PMCID:: PMC10296074

Abstract Article PDF–1.3M

Select item 93234864.

Brain mineralocorticoid receptor in health and disease: From molecular signalling to cognitive and emotional function

Susana N. Paul, Katja Wingenfeld, Christian Otte, Onno C. Meijer

Br J Pharmacol. 2022 Jul; 179(13): 3205–3219. Published online 2022 Apr 7. doi: 10.1111/bph.15835

PMCID:: PMC9323486

Abstract Article PDF–4.7M

Select item 99167505.

Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors

Mohammad Badran, Shawn B. Bender, David Gozal

Int J Mol Sci. 2023 Feb; 24(3): 2245. Published online 2023 Jan 23. doi: 10.3390/ijms24032245

PMCID:: PMC9916750

Abstract Article PDF–1.8M

Select item 78912466.

Aldosterone, Inflammation, Immune System, and Hypertension

Nathanne S Ferreira, Rita C Tostes, Pierre Paradis, Ernesto L Schiffrin

Am J Hypertens. 2021 Jan; 34(1): 15–27. Published online 2020 Aug 21. doi: 10.1093/ajh/hpaa137

PMCID:: PMC7891246

Abstract Article PDF–9.6M

Select item 62309007.

New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects

Ana Paula Davel, Iris Z. Jaffe, Rita C. Tostes, Frederic Jaisser, Eric J. Belin de Chantemèle

Am J Physiol Heart Circ Physiol. 2018 Oct 1; 315(4): H989–H999. Published online 2018 Jun 29. doi: 10.1152/ajpheart.00073.2018

PMCID:: PMC6230900

Abstract Article

Select item 54549448.

Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology

John W. Funder

Int J Mol Sci. 2017 May; 18(5): 1032. Published online 2017 May 11. doi: 10.3390/ijms18051032

PMCID:: PMC5454944

Abstract Article PDF–1.6M

Select item 108659279.

Role of aldosterone and mineralocorticoid receptor (MR) in addiction: a scoping review

Claire L. Pince, Kimberly E. Whiting, Tammy Wang, András H. Lékó, Lisa A. Farinelli, Diane Cooper, Mehdi Farokhnia, Leandro F. Vendruscolo, Lorenzo Leggio

Neurosci Biobehav Rev. Author manuscript; available in PMC 2024 Nov 1.

Published in final edited form as: Neurosci Biobehav Rev. 2023 Nov; 154: 105427. Published online 2023 Oct 17. doi: 10.1016/j.neubiorev.2023.105427

PMCID:: PMC10865927

Abstract Article PDF–1.3M

Select item 1156377810.

Aldosterone in the brain and cognition: knowns and unknowns

Anna Nieckarz, Beata Graff, Michel Burnier, Anna B. Marcinkowska, Krzysztof Narkiewicz

Front Endocrinol (Lausanne) 2024; 15: 1456211. Published online 2024 Nov 1. doi: 10.3389/fendo.2024.1456211

PMCID:: PMC11563778

Abstract Article PDF–578K

Select item 992272711.

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research

Argen Mamazhakypov, Achim Lother

Front Cardiovasc Med. 2023; 10: 1118516. Published online 2023 Jan 30. doi: 10.3389/fcvm.2023.1118516

PMCID:: PMC9922727

Abstract Article PDF–1.7M

Select item 798877312.

Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease

Guanghong Jia, Warren Lockette, James R. Sowers

Am J Physiol Regul Integr Comp Physiol. 2021 Mar 1; 320(3): R276–R286. Published online 2021 Jan 13. doi: 10.1152/ajpregu.00280.2020

PMCID:: PMC7988773

Abstract Article

Select item 311959313.

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure

Jean M Nappi, Adam Sieg

Vasc Health Risk Manag. 2011; 7: 353–363. Published online 2011 Jun 8. doi: 10.2147/VHRM.S13779

PMCID:: PMC3119593

Abstract Article PDF–193K

Select item 616534914.

Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease

Stefania Gorini, Vincenzo Marzolla, Caterina Mammi, Andrea Armani, Massimiliano Caprio

Biomolecules. 2018 Sep; 8(3): 96. Published online 2018 Sep 18. doi: 10.3390/biom8030096

PMCID:: PMC6165349

Abstract Article PDF–1.0M

Select item 395124215.

Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors

Dafina Pruthi, Amy McCurley, Mark Aronovitz, Carol Galayda, S. Ananth Karumanchi, Iris Z. Jaffe

Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2015 Feb 1.

Published in final edited form as: Arterioscler Thromb Vasc Biol. 2014 Feb; 34(2): 355–364. Published online 2013 Dec 5. doi: 10.1161/ATVBAHA.113.302854

PMCID:: PMC3951242

Abstract Article PDF–4.2M

Select item 751591116.

Aldosterone up-regulates voltage-gated potassium currents and NKCC1 protein membrane fractions

Parveen Bazard, Bo Ding, Harish K. Chittam, Xiaoxia Zhu, Thomas A. Parks, Thomas E. Taylor-Clark, Venkat R. Bhethanabotla, Robert D. Frisina, Joseph P. Walton

Sci Rep. 2020; 10: 15604. Published online 2020 Sep 24. doi: 10.1038/s41598-020-72450-4

PMCID:: PMC7515911

Abstract Article PDF–3.4M

Select item 1135426117.

Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models

Luka Varda, Robert Ekart, Mitja Lainscak, Uroš Maver, Sebastjan Bevc

Int J Mol Sci. 2024 Aug; 25(16): 9088. Published online 2024 Aug 22. doi: 10.3390/ijms25169088

PMCID:: PMC11354261

Abstract Article PDF–4.5M

Select item 1047114418.

G protein–coupled estrogen receptor: a promising therapeutic target for aldosterone-induced hypertension

Xuehan Li, Wenlong Kuang, Zhihua Qiu, Zihua Zhou

Front Endocrinol (Lausanne) 2023; 14: 1226458. Published online 2023 Aug 17. doi: 10.3389/fendo.2023.1226458

PMCID:: PMC10471144

Abstract Article PDF–1007K

Select item 960386319.

Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity—When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood

Bruno Griesler, Christin Schuelke, Christian Uhlig, Yekaterina Gadasheva, Claudia Grossmann

Int J Mol Sci. 2022 Oct; 23(20): 12592. Published online 2022 Oct 20. doi: 10.3390/ijms232012592

PMCID:: PMC9603863

Abstract Article PDF–989K

Select item 435624620.

Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease

Andrew S. Brem, Rujun Gong

Clin Sci (Lond) Author manuscript; available in PMC 2016 May 1.

Published in final edited form as: Clin Sci (Lond). 2015 May 1; 128(9): 527–535. doi: 10.1042/CS20140432

PMCID:: PMC4356246

Abstract Article PDF–597K

<< First< Prev

Page of 3358

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for aldosterone receptor

Figure 2A clinical algorithm for initiating aldosterone receptor antagonist therapy

*Combination therapy is defined as a renin-angiotensin inhibitor and either a thiazide diuretic or a calcium channel blocker. For patients on combination therapy without obesity or obstructive sleep apnea, therapy with either a vasodilating β-receptor antagonist or an aldosterone receptor antagonist should be considered.

Aldosterone Receptor Antagonists: Effective but Often Forgotten

Circulation. ;121(7):934-939.
Figure 2

Forest plot of CFR for ACEI and ARB. CFR, coronary flow reserve; ACEI, aldosterone receptor antagonist; ARB, aldosterone receptor antagonist.

Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve

Front Cardiovasc Med. 2020;7:580419.
Figure 8

Subgroup analysis of different CFR detection methods. ACEI, aldosterone receptor antagonist; ARB, aldosterone receptor antagonist; CCB, calcium channel blocker; CFR, coronary flow reserve.

Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve

Front Cardiovasc Med. 2020;7:580419.
Figure 7

Forest plot of CFR of different drugs in patients with myocardial ischemia symptoms. CFR, coronary flow reserve; ACEI, aldosterone receptor antagonist; ARB, aldosterone receptor antagonist; CCB, calcium channel blocker.

Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve

Front Cardiovasc Med. 2020;7:580419.